Clinical Trials

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06576635 2026-01-20

LUNG-05

29 enrolled

Phase NA Active not recruiting

NSCLC

NCT02921022 2025-11-26

Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma

110 enrolled

Pancreatic Neoplasms, Thromboembolism

NCT01495676 2025-10-10

GETUGV04

69 enrolled 9 charts

Urinary Bladder Neoplasms

NCT06292286 2025-06-11

SCENIC

18 enrolled

Gynecologic

Ovarian Neoplasms

NCT04894643 2025-05-08

PARC

10 enrolled

Pancreatic Neoplasms

NCT02512692 2024-11-18

Gemcitabine-Cisplatin-90Y TARE for Unresectable Intrahepatic Cholangiocarcinoma

6 enrolled

Cholangiocarcinoma

NCT06611345 2024-10-26

A Study of Tumor-Treating Fields in Combination With Durvalumab and Gemcitabine/Cisplatin in Biliary Tract Cancers

60 enrolled

Biliary Tract Neoplasms

NCT06349044 2024-08-27

A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies.

120 enrolled

Carcinoma, Hepatocellular

NCT06539806 2024-08-06

Clinical Study Evaluating the Effect of Losartan

90 enrolled

Phase NA Active not recruiting

Pancreatic Neoplasms

NCT05671900 2024-03-08

Gemcitabine and Docetaxel Therapy in High-risk BCG-naive Patients With Non-muscle Invasive Bladder Cancer

70 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT05626101 2024-02-13

Safety and Efficacy of Scheduled Intravesical Gemcitabine Versus Intravesical BCG for Intermediate and High Risk Non Muscle Invasive Bladder Cancer: A Prospective, Randomized Study

280 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT06211881 2024-01-18

Chi-GVM Regimen for the Treatment of R/R PTCL

Phase NA Not yet recruiting

50 enrolled

Lymphoid

Lymphoma, T-Cell, Peripheral

NCT05903703 2023-06-15

Canagliflozin With Gemcitabine in Pancreatic Carcinoma

Pancreatic Neoplasms

NCT05717790 2023-02-08

Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal Carcinoma

288 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT05352321 2022-07-01

Surgery Plus Target-reduction Chemoradiotherapy vs Regular Chemoradiotherapy for Newly Diagnosed Resectable Nasopharyngeal Carcinoma

264 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT00883480 2022-06-13

SLAT

153 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02733458 2021-09-14

GELAD Chemotherapy and Sandwiched Radiotherapy in the Treatment of Stage IE/IIE Natural Killer/T-cell Lymphoma

52 enrolled

Lymphoid

Lymphoma, Extranodal NK-T-Cell

NCT02778308 2021-04-06

Adjuvant Chemotherapy vs no Chemotherapy for Patients With GallBllader Carcinoma

100 enrolled

Gallbladder Neoplasms

NCT01938716 2020-11-05

Gemcitabine Pharmacokinetics After Preoperative Chemoradiation Therapy

12 enrolled 5 charts

Pancreatic Neoplasms

NCT02627807 2020-06-16

Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal Carcinoma

386 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT04432402 2020-06-16

Lenalidomide in Combination With R-GemOx in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma

124 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT02944357 2017-11-17

Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery

Phase NA Withdrawn

Infiltrating Bladder Urothelial Carcinoma

NCT00763516 2017-09-06

PC02

8 enrolled

Pancreatic Neoplasms

NCT00685763 2017-08-24

PC01

13 enrolled 3 charts

Pancreatic Neoplasms

NCT00448838 2016-12-15

Cetuximab, Gemcitabine, and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

42 enrolled

Pancreatic Neoplasms

NCT02716961 2016-03-24

Transurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy for Non-muscle-invasive Bladder Cancer

208 enrolled

Urinary Bladder Neoplasms, Recurrence

NCT02685228 2016-02-18

SLOWDOSE001

Pancreatic Neoplasms

NCT00614835 2015-12-22

Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus

25 enrolled

Gynecologic

Uterine Neoplasms

NCT01411072 2014-10-03

Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer

Pancreatic Neoplasms

NCT00673179 2014-09-10

Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy

7 enrolled 3 charts

Sarcoma

Osteosarcoma

NCT00159471 2014-05-22

Genes as Predictors of Response to Gemcitabine, Docetaxel, and Capecitabine (GTX) in Metastatic or Unresectable Pancreatic Cancer.

1 enrolled

Pancreatic Neoplasms

NCT00079365 2013-12-04

Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas

Pancreatic Neoplasms

NCT01442974 2013-03-13

Assessment Of Stromal Response To Nab-Paclitaxel In Combination With Gemcitabine In Pancreatic Cancer

15 enrolled

Pancreatic Neoplasms

NCT01801644 2013-03-01

Neoadjuvant Chemotherapy in Locally Advanced Bladder Cancer

60 enrolled

Urinary Bladder Neoplasms

NCT00003851 2013-02-15

Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic Cancer

90 enrolled

Pancreatic Neoplasms, Malnutrition

NCT01201044 2010-09-14

DO201001

80 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01125020 2010-05-18

Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver Transplantation

150 enrolled

Carcinoma, Hepatocellular, Neoplasm Metastasis, Recurrence

NCT00283478 2007-10-31

Iscar for Second Line Treatment of Advanced Non-Small Cell Lung Cancer